Is there transparency in the pricing of medicines in the South African private sector?

被引：0

作者：

Bangalee, V. ^{[1
]}

Suleman, F. ^{[1
,2
]}

机构：

[1] Univ KwaZulu Natal, Sch Hlth Sci, Discipline Pharmaceut Sci, Westville Campus, Durban, South Africa

[2] Univ Utrecht, Fac Sci, Prince Claus Chair Dev & Equ Theme Affordable, Utrecht, Netherlands

来源：

SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 2018年 / 108卷 / 02期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.7196/SAMJ.2018.v108i2.12815

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent investigations by the Competition Commission of South Africa (SA) of suspected excessive pricing of cancer medicines in SA by three global pharmaceutical companies have once again drawn attention to increasing medicine pricing transparency and warrant further public debate.

引用

页码：82 / 83

页数：2

共 50 条

[31] Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa
Phyllis Ocran Mattila
Zaheer-Ud-Din Babar
Fatima Suleman
[J]. BMC Health Services Research, 21
[32] Moving from a bad to a good pricing regime: The South African private health care market
Picard, Eric
Zimper, Alexander
[J]. SOUTH AFRICAN JOURNAL OF ECONOMICS, 2022, 90 (02) : 260 - 276
[33] Pharmaceutical pricing benchmarks: governmental versus private sector
Turkistani, Fatema
Bin Sawad, Aseel
[J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (15) : 1091 - 1100
[34] Trends in the utilization of medicines sold in the private sector post- registration in South Africa and the implications for similar countries
Ntobeko Magnate Mpanza
Brian Godman
Mothobi Godfrey Keele
Moliehi Matlala
[J]. BMC Public Health, 23
[35] Trends in the utilization of medicines sold in the private sector post- registration in South Africa and the implications for similar countries
Mpanza, Ntobeko Magnate
Godman, Brian
Keele, Mothobi Godfrey
Matlala, Moliehi
[J]. BMC PUBLIC HEALTH, 2023, 23 (01)
[36] Devil's in the detail: how to assess transformation of the South African private sector1
Joubert, Michelle
[J]. TRANSFORMATION-CRITICAL PERSPECTIVES ON SOUTHERN AFRICA, 2022, 109 : 51 - 79
[37] The Role of Central Bank Transparency for Guiding Private Sector Forecasts
Ehrmann, Michael
Eijffinger, Sylvester
Fratzscher, Marcel
[J]. SCANDINAVIAN JOURNAL OF ECONOMICS, 2012, 114 (03): : 1018 - 1052
[38] Can a multistakeholder initiative improve transparency and accountability in the pharmaceutical sector? Evidence from the Medicines Transparency Alliance
Vian, Taryn
Kohler, Jillian Clare
Dimancesco, Deirdre
Forte, Gilles
[J]. LANCET GLOBAL HEALTH, 2017, 5 : 6 - 6
[39] Training, guideline access and knowledge of antiretroviral interactions: Is the South African private sector being left behind?
Chisholm, B. S.
Swart, A. M.
Blockman, M.
[J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2022, 112 (10): : 806 - 811
[40] National survey of paediatric audiological services for diagnosis and intervention in the South African private health care sector
Meyer, Miriam E.
Swanepoel, De Wet
le Roux, Talita
[J]. SOUTH AFRICAN JOURNAL OF COMMUNICATION DISORDERS, 2014, 61 (01)

← 1 2 3 4 5 →